Anti-GCET1 antibody [EPR12224]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal GCET1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
GCET1, SERPINA11, UNQ692/PRO1337, SERPINA9, Serpin A9, Centerin, Germinal center B-cell-expressed transcript 1 protein
- WB
Supplier Data
Western blot - Anti-GCET1 antibody [EPR12224] (AB179814)
All lanes:
Western blot - Anti-GCET1 antibody [EPR12224] (ab179814) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
Raji cell lysate at 10 µg
Lane 3:
Daudi cell lysate at 10 µg
Predicted band size: 47 kDa
false
Related conjugates and formulations (1)
-
Anti-GCET1 antibody [EPR12224] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GCET1 participates in the regulation of B-cell proliferation and survival although it is not itself a signaling molecule. It operates mainly within the immune system particularly affecting B-cells. This protein does not typically form part of a larger complex but may influence the activity of other proteins tied to B-cell activation and development aiding in the control of immune responses.
Pathways
GCET1 shows involvement with B-cell receptor signaling and associated signaling pathways. These pathways are central to lymphocyte development activation and differentiation. It interacts closely with essential signaling proteins like SYK and BLNK. Alterations in these pathways can contribute to improper B-cell functioning and linked immunological abnormalities.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Cancer drug resistance (Alhambra, Calif.) 8:26 PubMed40521302
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com